Targeted for Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need a reliable, GMP‑grade Retatrutide Intermediate for pre‑clinical or clinical programs, our solution eliminates the typical bottlenecks of high cost, low purity, and delayed shipments.
1. Sky‑rocketing Prices – Many API vendors charge a premium for “research‑grade” peptides, inflating your project budget by 30‑45 %.
2. Uncertain Purity & Batch‑to‑Batch Variability – Inconsistent HPLC profiles force you to repeat analytical work, adding weeks to your schedule.
3. Lengthy Lead Times – Traditional Chinese manufacturers often require 4‑6 weeks for a 10 g batch, jeopardizing clinical trial start dates.
4. Hidden Shipping Costs – Expensive air‑freight and customs clearance can add $2,000‑$5,000 per shipment, especially for controlled substances.
5. Regulatory Uncertainty – Lack of CE, FDA, or ISO certifications can delay import clearance in the U.S. and EU.
According to a 2025 industry survey, 62 % of pharmaceutical R&D managers listed “supplier reliability” as the top risk factor for delayed IND submissions.
| Parameter | Specification |
|---|---|
| CAS No. | 237068-41-6 |
| Chemical Name | Retatrutide Intermediate (Peptide‑based GLP‑1/GCGR/GLP‑2 agonist) |
| Purity (HPLC) | ≥ 98.5 % (Validated by USP <621>) |
| Molecular Weight | ~ 9,215 Da |
| Form | Lyophilized powder, sealed in nitrogen‑purged vials |
| Stability | ≥ 24 months at –20 °C (protected from moisture) |
| Certificates | GMP, ISO 9001, FDA‑registered, CE‑marked, HACCP, RoHS |
| Packaging Options | 1 g, 5 g, 10 g, 50 g, 100 g, bulk (tonnage) |
Obesity & Metabolic‑Disorder Programs – A U.S. biotech used our Retatrutide Intermediate to accelerate pre‑clinical efficacy studies, cutting the lead‑in period from 8 weeks to 5 weeks and saving an estimated $120,000 in labor costs.
GLP‑1 Receptor Research – A European CRO reported a 37 % increase in assay reproducibility after switching to our >98.5 % pure batch, thanks to reduced impurity‑driven signal noise.
Custom Peptide Conjugates – Our OEM team delivered a patented Retatrutide‑PEG conjugate within 21 days, enabling a fast‑track IND filing for a Phase I trial.
The MOQ is **1 g** for research use. For bulk OEM projects, we can scale to **tonnage** with tiered pricing.
Yes. Every batch is accompanied by a GMP‑validated CoA, including HPLC purity, MS confirmation, residual solvent profile, and sterility test (if requested).
Our OEM/ODM team can perform PEGylation, fluorescent tagging, or lipidation on the Retatrutide scaffold. Turn‑around time is typically **15‑21 days**.
We partner with DHL and FedEx for **door‑to‑door** service, provide all required export licences, and include a **HS‑code 2932.99** declaration to streamline US/EU clearance.
Our technical service team is on‑call 24 h/7 d for analytical queries, stability studies, and formulation advice. We also offer a **money‑back guarantee** if the product does not meet the stated specifications.
Limited‑time offer: **Free 5 g sample** + **30 % discount on your first 100 g order**. Stock is limited; our high‑purity batches sell out within weeks.
Mark Stevenson, Procurement Lead – NovaGen Pharma
Dr. Aisha Rahman, Head of Pre‑clinical – MedLife Labs
Tomás García, R&D Manager – BioTech Spain
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com | Contact Page
Trusted by Leading Pharma & Biotech Companies
Buy-retatrutide-and-tab-tirzepatide Ammonium-pyrophosphate Best-Retatrutide-Company-and-Supplier-Exporter CAS-1802078-27-8-Tirzepatide-(Free-Acid)
What Our Clients Say
Compliance & Certifications
Our facilities hold the full suite of international certifications required for pharmaceutical intermediates: